Henderson C et al. |
Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA). |
2003 |
J. Biol. Chem. |
pmid:12556448
|
Palazzo A et al. |
Cell biology: Tubulin acetylation and cell motility. |
2003 |
Nature |
pmid:12529632
|
Fernandes I et al. |
Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. |
2003 |
Mol. Cell |
pmid:12535528
|
Cheutin T et al. |
Maintenance of stable heterochromatin domains by dynamic HP1 binding. |
2003 |
Science |
pmid:12560555
|
Boutillier AL et al. |
Selective E2F-dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis. |
2003 |
J. Neurochem. |
pmid:12562525
|
Tomita K et al. |
The effect of oxidative stress on histone acetylation and IL-8 release. |
2003 |
Biochem. Biophys. Res. Commun. |
pmid:12565901
|
Kim Y et al. |
Decreased syndecan-2 expression correlates with trichostatin-A induced-morphological changes and reduced tumorigenic activity in colon carcinoma cells. |
2003 |
Oncogene |
pmid:12584561
|
Musikacharoen T et al. |
Histone acetylation and activation of cAMP-response element-binding protein regulate transcriptional activation of MKP-M in lipopolysaccharide-stimulated macrophages. |
2003 |
J. Biol. Chem. |
pmid:12511574
|
Gusterson RJ et al. |
The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity. |
2003 |
J. Biol. Chem. |
pmid:12477714
|
Kondo Y et al. |
Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. |
2003 |
Mol. Cell. Biol. |
pmid:12482974
|
Ding Z et al. |
Human MI-ER1 alpha and beta function as transcriptional repressors by recruitment of histone deacetylase 1 to their conserved ELM2 domain. |
2003 |
Mol. Cell. Biol. |
pmid:12482978
|
Kim DK et al. |
Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors. |
2003 |
J. Med. Chem. |
pmid:14667227
|
Obata T et al. |
Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer. |
2003 |
Clin. Cancer Res. |
pmid:14695142
|
Terui T et al. |
Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors. |
2003 |
Cancer Res. |
pmid:14695212
|
Le Masson I et al. |
Yaf9, a novel NuA4 histone acetyltransferase subunit, is required for the cellular response to spindle stress in yeast. |
2003 |
Mol. Cell. Biol. |
pmid:12917332
|
Zhong S et al. |
Phosphorylation at serine 28 and acetylation at lysine 9 of histone H3 induced by trichostatin A. |
2003 |
Oncogene |
pmid:12917630
|
Condon JC et al. |
A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. |
2003 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12886011
|
Ryu JR and Arnosti DN |
Functional similarity of Knirps CtBP-dependent and CtBP-independent transcriptional repressor activities. |
2003 |
Nucleic Acids Res. |
pmid:12888527
|
Pivot-Pajot C et al. |
Acetylation-dependent chromatin reorganization by BRDT, a testis-specific bromodomain-containing protein. |
2003 |
Mol. Cell. Biol. |
pmid:12861021
|
Grassi G et al. |
Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87. |
2003 |
Carcinogenesis |
pmid:12869421
|
Ammanamanchi S et al. |
Acetylated sp3 is a transcriptional activator. |
2003 |
J. Biol. Chem. |
pmid:12837748
|
Krämer OH et al. |
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. |
2003 |
EMBO J. |
pmid:12840003
|
Kishikawa S et al. |
Control elements of Dnmt1 gene are regulated in cell-cycle dependent manner. |
2003 |
Nucleic Acids Res. Suppl. |
pmid:14510503
|
Wegener D et al. |
Improved fluorogenic histone deacetylase assay for high-throughput-screening applications. |
2003 |
Anal. Biochem. |
pmid:14511685
|
Kim MS et al. |
Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. |
2003 |
Cancer Res. |
pmid:14612526
|
Miller TA et al. |
Histone deacetylase inhibitors. |
2003 |
J. Med. Chem. |
pmid:14613312
|
Hitomi T et al. |
p15(INK4b) in HDAC inhibitor-induced growth arrest. |
2003 |
FEBS Lett. |
pmid:14623092
|
Liu LT et al. |
Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. |
2003 |
Cancer Res. |
pmid:12810630
|
Shin HJ et al. |
Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation. |
2003 |
Oncogene |
pmid:12813458
|
Kim TY et al. |
Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. |
2003 |
Oncogene |
pmid:12813468
|
Kim JM et al. |
Changes in histone acetylation during mouse oocyte meiosis. |
2003 |
J. Cell Biol. |
pmid:12835313
|
Camarero N et al. |
Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site. |
2003 |
Nucleic Acids Res. |
pmid:12626711
|
Park KK et al. |
Modulation of Sp1-dependent transcription by a cis-acting E2F element in dhfr promoter. |
2003 |
Biochem. Biophys. Res. Commun. |
pmid:12788094
|
Marks J et al. |
Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter. |
2003 |
J. Biol. Chem. |
pmid:12791684
|
Valls E et al. |
The SV40 T antigen modulates CBP histone acetyltransferase activity. |
2003 |
Nucleic Acids Res. |
pmid:12799439
|
Ferguson M et al. |
Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene. |
2003 |
Nucleic Acids Res. |
pmid:12799440
|
Ji Y et al. |
A multistep mechanism for the activation of rearrangement in the immune system. |
2003 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12802019
|
Nemajerová A et al. |
Trichostatin A suppresses transformation by the v-myb oncogene in BM2 cells. |
2003 |
J. Hematother. Stem Cell Res. |
pmid:12804181
|
Cimini D et al. |
Histone hyperacetylation in mitosis prevents sister chromatid separation and produces chromosome segregation defects. |
2003 |
Mol. Biol. Cell |
pmid:12972566
|
Schuettengruber B et al. |
Autoregulation of mouse histone deacetylase 1 expression. |
2003 |
Mol. Cell. Biol. |
pmid:12972616
|
Yang Y et al. |
The histone code regulating expression of the imprinted mouse Igf2r gene. |
2003 |
Endocrinology |
pmid:12975326
|
Hu E et al. |
Identification of novel isoform-selective inhibitors within class I histone deacetylases. |
2003 |
J. Pharmacol. Exp. Ther. |
pmid:12975486
|
Craig JM et al. |
Centromeric chromatin pliability and memory at a human neocentromere. |
2003 |
EMBO J. |
pmid:12743043
|
Enright BP et al. |
Epigenetic characteristics and development of embryos cloned from donor cells treated by trichostatin A or 5-aza-2'-deoxycytidine. |
2003 |
Biol. Reprod. |
pmid:12748129
|
Van Ommeslaeghe K et al. |
Amide analogues of TSA: synthesis, binding mode analysis and HDAC inhibition. |
2003 |
Bioorg. Med. Chem. Lett. |
pmid:12749885
|
Zhao S et al. |
Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. |
2003 |
Cancer Res. |
pmid:12750289
|
Schauber J et al. |
Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. |
2003 |
Gut |
pmid:12692061
|
Rambhatla L et al. |
Generation of hepatocyte-like cells from human embryonic stem cells. |
2003 |
Cell Transplant |
pmid:12693659
|
Lee SC et al. |
Activation of terminal B cell differentiation by inhibition of histone deacetylation. |
2003 |
Mol. Immunol. |
pmid:12695118
|
Teyssier C et al. |
Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect. |
2003 |
Mol. Endocrinol. |
pmid:12554755
|